Mankind Pharma may offer investors a better entry point after its listing

April 25, 2023

Business: Unlike its peers, Mankind Pharma started in rural India and is now expanding to urban India. The company earns 97% of its revenues from India. It has also been a uniquely successful player in building branded consumer product portfolios. The company is a market leader in multiple categories – male condoms with its brand Manforce, pregnancy detection kits with PregaNews, and emergency contraceptives with its pill Unwanted-72.

More To Explore

Sebi proposes tighter curbs on promotional claims by online bond platforms

Sebi is tightening the reins on advertising practices for online bond platforms, aiming to protect investors from hasty decisions. New rules mandate that promotional content

August 22, 2026

Dalal Street Week Ahead: Selective Buying Favoured as Nifty Remains Range-Bound

Nifty remained range-bound, falling 0.47% to 24,252 amid subdued volatility. Resistance at 24,450–24,750 remains crucial, while 23,900–24,100 offers support. Analysts recommend selective, stock-specific positioning until

August 22, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003